More specifically, CyPA was reported to be critically involved in vascular remodeling [32], cardiac hypertrophy [33], as well as in AAA formation [17], where its release by VSMC negatively contributes in disease development. This evidence concerns the gene PPIA and cardiac hypertrophy.